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Epithelial tumours of the skin (including both basal cell and squa-
mous cell carcinomas) are highly invasive locally. It is not
uncommon for such tumours to spread widely through the stroma,
and to penetrate by direct extension into subcutaneous fat, muscle,
cartilage and bone. Damage to host tissue is often extensive
(Weedon, 1997; Brodland, 1998). Mechanisms of tissue invasion
by epithelial tumours are not completely understood. Based on
findings in a number of experimental models, it is believed that
stromal invasion by epithelial tumours involves epithelial cell
proliferation, induction of motility in the invasive cells and the 
up-regulation of tissue-destructive matrix metalloproteinases
(MMPs) (Clark, 1991; Stetler-Stevenson et al, 1993; Werb, 1997;
Herouy, 2001). 
It is difficult to know precisely how the invasion process in exper-
imental models mimics human tumour invasion under in situ condi-
tions. As a novel way to address this issue, we have developed a
model of stromal invasion by epithelial cells in organ-cultured
human skin. This model of invasion is based on the finding that
while normal histological structure and biochemical function are
maintained in human skin under serum-free, growth factor-free
conditions (Varani et al, 1993, 1994), exposure of skin in organ
culture to exogenous EGF results in epidermal hyperplasia associ-
ated with abnormal differentiation and acantholysis in the upper
epidermis, erosion of the epithelial–dermal basement membrane and
penetration of epithelial cells into the stroma. In places, individual
isolated epithelial cells can be seen completely surrounded by
stroma (Fligiel and Varani, 1993; Zeigler et al, 1996a). Invasion in
organ-cultured skin is accompanied by MMP up-regulation and acti-
vation (Fligiel and Varani, 1993; Varani et al, 1995; Zeigler et al,
1996a, 1996b), and is inhibited in the presence of tissue inhibitor of
metalloproteinase-2 (TIMP-2) (Zeigler et al, 1996b). 
The present study continues our efforts to delineate cellular and
molecular events that contribute to invasion in this model. Here we
show that keratinocyte proliferation and elaboration of MMP-9
(92-kD gelatinase B) are stimulated by EGF and inhibited (both
in monolayer culture and organ culture) by a potent, irreversible
pharmacological antagonist of EGF receptor tyrosine kinase
(EGF-RTK). Further studies reveal that dermal fibroblast prolifer-
ation and MMP-1 (interstitial collagenase) production also occur
following EGF stimulation. These events occur, at least in part, in
response to factors elaborated by epidermal cells. Fibroblast
proliferation is strongly inhibited by the same EGF-RTK antago-
nist that blocks keratinocyte proliferation. In contrast, MMP-1
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production is resistant to EGF-RTK antagonism but inhibited by
interleukin-1 receptor antagonism. 
MATERIALS AND METHODS 
Reagents 
The EGF-RTK antagonist used in these studies was a generous gift
of Drs WL Leopold and David Fry of Pfizer Global Research and
Development, Ann Arbor Laboratories, Ann Arbor, MI. The
compound, designated as PD169540, is an acrylamide-substituted
4-anilinopyrido[d]pyrimidine designed to irreversibly alkylate
Cys-773 within the ATP-binding pocket of c-erbB1 and c-erbB2
(EGF receptor family members) (Smaill et al, 2000). Recombinant
forms of human EGF, interleukin-1β (IL-1β ) and IL-1 Receptor
Antagonist were obtained from R&D Systems (Minneapolis, MN). 
Human skin organ cultures 
Replicate 2 mm full-thickness punch biopsies of sun-protected hip
skin were obtained from adult volunteers. Immediately upon
biopsy, the tissue was immersed in culture medium consisting of
Keratinocyte Basal Medium (KBM) (Clonetics, Inc, Walkersville,
MD). KBM is a low-Ca2+ (0.15 mM) serum-free modification
of MCDB-153 medium optimized for high-density keratinocyte
growth (Boyce and Ham, 1983). The culture medium was supple-
mented with CaCl2 to bring the final Ca2+ concentration to 1.4 mM.
This was done because previous studies had shown that survival
of human skin in organ culture depends on a Ca2+ concentration
that is optimized for fibroblast survival and growth (Varani et al,
1993, 1994). After transport to the laboratory on ice, the biopsies
were incubated in wells of a 96-well dish containing 200 µ l of
Ca2+-supplemented KBM with or without additional treatments.
Cultures were incubated at 37˚C in an atmosphere of 95% air and
5% CO2. Incubation was for 8 days, with change of medium
containing the various treatments every 2 days. At the end of the
incubation period, tissue was fixed in 10% buffered formalin and
examined histologically after staining with haematoxylin and
eosin. All procedures involving human subjects were approved by
the University of Michigan Institutional Review Board, and all
subjects provided written informed consent prior to inclusion in
the study. 
Human epidermal keratinocytes in monolayer culture 
Additional skin biopsies were used for isolation of keratinocytes
and fibroblasts. Normal human epidermal keratinocytes were
obtained as described previously (Varani et al, 1994) and main-
tained in monolayer culture using Keratinocyte Growth Medium
(KGM) (Clonetics, Inc). KGM contains the same basal medium as
KBM, but is further supplemented with a mixture of growth
factors including 0.1 ng ml–1 EGF, 0.5 µ g ml–1 insulin, and 2%
bovine pituitary extract. Growth was at 37˚C in an atmosphere of
95% air and 5% CO2. Cells were sub-cultured by exposure to
trypsin/EDTA and used at passage 2–3. In some experiments, the
HaCaT line of immortalized human epidermal keratinocytes
(Boukamp et al, 1988) was used in place of normal keratinocytes.
HaCaT cells were propagated in exactly the same manner as 
low-passage keratinocytes, and used interchangeably with
keratinocytes. 
Culture fluid was prepared from keratinocyte or HaCaT cultures
as follows. The cells were plated at 4 × 104 cells cm–2 of surface
area in 25 cm2 or 75 cm2 flasks. KGM was used as culture
medium. When the cultures were approximately 75% confluent,
the cells were washed 2 times in KBM and incubated for 72 hours
in KBM supplemented with 1.4 mM Ca2+. At the end of the incu-
bation period, the culture fluid was collected and separated from
cells and debris by low-speed centrifugation. The keratinocyte
culture fluid was used as a source of ‘stimulating factor(s)’ for
dermal fibroblast proliferation and MMP-1 production. 
Human dermal fibroblasts in monolayer culture 
Normal human dermal fibroblasts were isolated as described
previously (Varani et al, 1994) and grown in monolayer culture
using Dulbecco’s Modified Minimal Essential Medium supple-
mented with non-essential amino acids and 10% fetal bovine
serum (DMEM-FBS) as culture medium. Fibroblasts were main-
tained at 37˚C in an atmosphere of 95% air and 5% CO2. Cells
were sub-cultured by exposure to trypsin/EDTA and used at
passage 2–5. 
For proliferation assays, dermal fibroblasts were plated at 
2 × 104 cells cm–2 of surface area in wells of a 24-well dish using
DMEM-FBS as growth medium. After allowing cells to attach,
the medium was removed and the cells washed twice in Ca2+-
supplemented KBM. The cells were then incubated for 72 hours
in Ca2+-supplemented KBM with or without keratinocyte culture
fluid and/or additional reagents as indicated in Results. At the
end of the incubation period, the cells were harvested by
trypsinization and enumerated using an automated particle
counter. Culture fluid was obtained and clarified by low-speed
centrifugation, following which it was assayed for MMP-1 as
indicated below. 
Substrate-embedded enzymography 
SDS-PAGE substrate-embedded enzymography (zymography)
was used to identify enzymes with collagenase and gelatinase
activities. Assays were carried out exactly as described in a
previous report (Gibbs et al, 1999). Briefly, denatured but non-
reduced culture fluid samples were resolved in 7.5% SDS-PAGE
gels prepared with the added incorporation of gelatin (1 mg ml–1)
or β -casein (1 mg ml–1) prior to casting. After electrophoresis, gels
were washed twice for 15 min in 50 mM Tris buffer containing
1 mM Ca2+, 0.5 mM Zn2+ and 2.5% Triton X-100. The gels were
then incubated overnight in Tris buffer with 1% Triton X-100 and
stained the following day with Coumassie Brilliant Blue 250-R.
Following destaining, zones of enzyme activity were detected as
regions of negative staining against the dark background. The
zymograms were converted to negative images and digitized.
Quantitation was accomplished by determining the number of
pixels in the negative images. For organ cultures, data were
normalized per biopsy. For cell cultures, data were normalized to
an equivalent number of cells. Volumes of 5–35 µ l of undiluted
organ culture or cell culture fluid were normally used for these
assays; zones of activity were proportional to the quantity of
culture fluid used. Gelatin zymography is useful for detection of
MMP-2 (72-kD gelatinase A) and MMP-9. β -casein zymography
is useful for detection of MMP-1, which appears as a doublet
in the 54-kD region of the gel. The β -casein zymographic bands
co-migrate with purified MMP-1 as detected in Western blotting1602 SE Moon et al
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(Varani et al, 2000). Digestion of native, fibrillar type I collagen
was observed in parallel with expression of MMP-1, and blocked
in the presence of TIMP-2 or EDTA but not with a battery of serine
proteinase inhibitors (Varani et al, 2000). 
RESULTS 
Effects of EGF-RTK antagonism on proliferation 
and abnormal differentiation induced by EGF in 
organ-cultured skin 
In the first series of experiments, organ cultures of adult human
skin were incubated for 8 days in serum-free, growth factor-free
culture medium (i.e., KBM containing 1.4 mM Ca2+) or in the
same medium supplemented with 10 nM EGF and/or 1 µ M EGF-
RTK antagonist. As shown in Figure 1, normal histological archi-
tecture was preserved in control tissue. Consistent with previous
reports (Varani et al, 1993, 1994), the histological appearance of
the tissue resembled that of freshly biopsied skin. Basal epithelial
cells were mainly columnar in shape, with orderly stratification of
suprabasal keratinocytes. In the absence of exogenous EGF, the
irreversible EGF-RTK antagonist at concentrations as high as
1 µ M had no demonstrable effect on histology (not shown). 
The appearance of EGF-treated tissue was significantly different
from that of control tissue (Figure 1). The epidermis was thickened,
due to an increase in the number of epidermal keratinocytes.
Routinely, epidermal cell down-growth into stromal space was
observed, and in places, isolated epithelial cells could be seen
surrounded by stroma. The epidermis of EGF-treated tissue was
more disorganized than that of control tissue, with loss of the
normal progression from basal to spinous to granular layers. Loss
of suprabasal keratinocyte cohesion was frequently observed,
leading to acantholysis and partial or complete separation of the
upper spinous layers in many of the EGF-treated specimens. These
histological changes observed in the presence of exogenous EGF
are consistent with what has been described in previous reports
(Fligiel and Varani, 1993; Zeigler et al, 1996a, 1996b). 
Figure 1 also demonstrates the histological appearance of
human skin after 8 days in organ culture in the presence of exoge-
nous EGF and the irreversible EGF-RTK antagonist. It can be seen
that the antagonist reversed the effects of 10 nM EGF at the
concentration used (1 µ M). The histological appearance of organ
cultures treated with EGF + PD169540 was very similar to that of
control organ cultures not treated with either reagent. It has been
established previously that this concentration of PD169540 is
without effect on tyrosine kinases residing outside the EGF
receptor family (Smaill et al, 2000). The effect of the antagonist
was dose-dependent: 0.5 µ M PD169540 was also effective, albeit
less so than 1 µ M, whereas lower concentrations had no effect
(data not shown). 
Effects of EGF-RTK antagonism on MMP-1 and MMP-9
production in organ-cultured skin 
Culture fluids were obtained from control organ-cultures (i.e., from
tissue incubated in KBM supplemented with 1.4 mM Ca2+) and
from cultures treated with 10 ng ml–1 EGF in the absence or pres-
ence of the EGF-RTK antagonist. Exposure of the skin in organ
culture to EGF resulted in up-regulation of MMP-1 and MMP-9
without a major change in MMP-2 expression (Figure 2).
Consistent with past findings (Varani et al, 1995; Zeigler et al,
1996b), MMP-9 up-regulation occurred rapidly (evident within 2
days and maximal by day 4). MMP-1 up-regulation occurred
Control EGF EGF & PD169540
Figure 1 EGF-RTK antagonism reverses histological features associated with stromal invasion in EGF-treated, organ-cultured skin. Human skin was
maintained in organ culture for 8 days. At the end of the incubation period, tissue was stained with haematoxylin and eosin. The histological appearances
depicted in the 3 panels were consistent among skin organ cultures from 8 different individuals 
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Figure 2 EGF-RTK antagonism inhibits MMP-9 and MMP-1 up-regulation in
EGF-treated, organ-cultured skin. Human skin was maintained in organ
culture for 8 days. Organ culture fluid was collected at 2-day intervals and
assessed by gelatin and β -casein zymography. Upper panel: Gelatin
zymography (day 4): MMP-9 (gelatinase B) is observed at the 92-kD locus
while MMP-2 (gelatinase A) is seen at the 72-kD locus. Lower panel: β -
casein zymography (day 6): MMP-1 (interstitial collagenase) is seen as a
doublet at the 54-kD locus. Lane 1, KBM + Ca2+; lane 2, KBM + Ca2+ + 
10 ng ml–1 EGF, lanes 3 and 4, same as lane 2 except with 0.5 and 1.0 µ M
PD169540, respectively. The findings depicted here were consistent with
organ cultures from 5 different individuals MMP-1 and invasion 1603
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more slowly; differences between control and EGF-treated tissue
were not routinely observed until day 6–8. In the presence of
PD169540, MMP-9 production was substantially reduced without a
detectable change in MMP-2 (Figure 2, upper panel). The concentra-
tions of antagonist that inhibited enzyme induction (0.5 – 1.0 µ M)
were the same concentrations that also blocked epidermal prolifera-
tion, abnormal differentiation and stromal invasion. MMP-1 elabo-
ration was also inhibited in the presence of PD169540 (Figure 2,
lower panel). In contrast to MMP-9, where production was inhib-
ited to below basal levels, MMP-1 was inhibited only modestly and
only at the highest concentration of antagonist. 
Effects of EGF-RTK antagonism on fibroblast
proliferation and fibroblast production of MMP-1 in
response to keratinocyte-derived factors 
Based on previous studies in several laboratories including our own
(Varani et al, 1995; Fisher et al, 1997; Varani et al, 2000), it is
accepted that the epidermis is the major source of MMP-9 in the skin.
It is further known that up-regulation of MMP-9 in keratinocytes
following stimulation with growth factors (including EGF) is a
direct consequence of signalling through mitogen-activated protein
(MAP) kinase cascades leading to formation of the AP-1 transcrip-
tion complex and MMP-9 gene transcription (Zeigler et al, 1999).
Although epidermal keratinocytes are also capable of synthesizing
MMP-1 (Bauer et al, 1977; Goslen and Bauer, 1986; Pilcher et al,
1999), dermal fibroblasts appear to be the major source of this
enzyme in skin (Fisher et al, 1997). The sequence of events leading
to induction of MMP-1 in the dermis of growth factor-treated skin
is not fully understood. Here we present evidence that factors
released from keratinocytes are able to stimulate MMP-1 produc-
tion (as well as growth) in dermal fibroblasts. 
In the presence of keratinocyte-conditioned culture fluid (500 µ l
of culture fluid per ml of medium), fibroblast growth and MMP-1
production were both stimulated (Figure 3). Additional studies
demonstrated that concentrations of keratinocyte culture fluid
as low as 50–100 µ l ml–1 were effective (not shown). It can be
seen from Figure 3 (upper panel) that the same concentrations of
PD169540 that inhibited invasion in organ culture (0.5 –1.0 µ M,
see above) also suppressed keratinocyte-induced fibroblast growth
(greater than 95% inhibition). PD169540 also inhibited fibroblast
production of MMP-1 in response to keratinocyte culture fluid.
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Figure 3 EGF-RTK antagonism inhibits human dermal fibroblast proliferation
and MMP-1 production in response to culture fluid from human epidermal
keratinocytes. Upper panel: Proliferation: Values are presented as
proliferation indices; i.e., the ratio of cells present at the end of the 48 hour
incubation period to cells present at time-zero ± standard deviations in a
single experiment. The experiment was repeated 4 times with similar results.
Lower panel: MMP-1 production: Values shown represent densitometry
scans of the 54-kD bands in β -casein gels, and quantification of the digitized
scans. Values are presented as stimulation indices; i.e., the ratio of pixels in
each of the treatment groups (closed bars) to pixels in the control group (open
bar). The experiment was repeated 4 times with similar results. The insert
demonstrates 54-kD β -caseinolytic activity elaborated by control fibroblasts
(lane 1), fibroblasts exposed to keratinocyte culture fluid (lane 2) or fibroblasts
exposed to 1 µ M PD169540 along with keratinocyte culture fluid (lane 3) 
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Figure 4 IL-1 receptor antagonism fails to inhibit fibroblast proliferation in
monolayer culture induced by culture fluid from human epidermal
keratinocytes but inhibits MMP-1 up-regulation induced in the same cells.
Upper panel: Proliferation assay. Values are presented as proliferation
indices; i.e., the ratio of cells present at the end of the 48 hour incubation
period to cells present at time-zero ± standard deviations in a single
experiment. The experiment was repeated 4 times with similar results.
Lower panel: MMP-1 up-regulation. Values shown represent densitometry
scans of the 54-kD bands in β -casein gels, and quantification of the digitized
scans. Values are presented as stimulation indices; i.e., the ratio of pixels in
each of the treatment groups (closed bars) to pixels in the control group
(open bar). The experiment was repeated four times with similar results. The
insert demonstrates 54-kD β -caseinolytic activity elaborated by control
fibroblasts (lane 1), fibroblasts exposed to keratinocyte culture fluid (lane 2)
or fibroblasts exposed to 25 or 50 µ gm l -1 of the IL-1 receptor antagonist 
(IL-1 RA) along with keratinocyte culture fluid (lanes 3 and 4).1604 SE Moon et al
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In contrast to its effects on proliferation, however, only modest
inhibition of MMP-1 production (approximately 20%) was seen
(Figure 3, lower panel). Control studies carried out in parallel
demonstrated that fibroblast proliferation and MMP-1 production
induced by exogenous EGF (0.1–10 ng ml–1) were both
completely inhibited in the presence of the EGF-RTK antagonist
(not shown). 
Since EGF-RTK antagonism was only modestly effective in
preventing the induction of MMP-1 by keratinocyte culture fluid,
additional studies were conducted in which fibroblasts were
exposed to the same culture fluid and concomitantly treated with
human recombinant IL-1 Receptor Antagonist. In the presence of
the IL-1 Receptor Antagonist (25–50 µ g ml–1), keratinocyte
culture fluid stimulation of fibroblast proliferation was unaffected,
while MMP-1 production was reduced by approximately 70–80%
(Figure 4). Additional studies showed that concentrations of IL-1
Receptor antagonist as low as 10 µ g ml–1 were effective in inhibit-
ing MMP-1 up-regulation. Not surprisingly, the IL-1 Receptor
Antagonist also prevented MMP-1 induction by exogenous IL-1β ,
but had no effect on EGF-stimulated MMP-1 production (not
shown).
DISCUSSION 
Invasion of the stroma by epithelial cells in growth factor-treated
human skin is associated with keratinocyte proliferation and up-
regulation of MMP-9 (Fligiel and Varani, 1993; Varani et al, 1995;
Zeigler et al, 1996a, 1996b). Exposure of epidermal keratinocytes
in monolayer culture to the same growth factors duplicates these
effects on proliferation and MMP-9 production (Varani et al, 1995;
Zeigler et al, 1996a, 1996b). The present studies demonstrate that
blocking EGF-RTK activity inhibits epidermal proliferation and
MMP-9 production in organ culture and monolayer culture, and
concomitantly prevents stromal invasion in organ culture. Taken
together, these in vitro and in vivo findings strongly suggest that
invasion-associated events in the epidermis occur as a direct
consequence of EGF receptor activation on the keratinocyte
surface. 
Although events occurring in the epidermis are, undoubtedly,
critical for stromal invasion by epithelial cells, it is likely that
events occurring in the dermis are important as well. Specifically,
the destruction of stromal connective tissue by collagenolytic
enzymes is an important feature of epithelial tumour invasion. This
is particularly important in the skin, where the stroma consists of a
thick, dense collagenous matrix (Bauer et al, 1977; Goslen and
Bauer, 1986; Weedon, 1997; Brodland, 1998). Although there are at
least 3 mammalian collagenolytic enzymes that can mediate
destruction of type I collagen, our recent studies suggest that MMP-
1 is the major enzyme involved in this process (Varani et al, 2000).
Other recent data also suggest that although epithelial cells can
elaborate collagenolytic enzymes including MMP-1 (Pilcher et al,
1999), the major source of these enzymes is the dermis (Fisher et al,
1997; Varani et al, 2000). Here we show that regulation of MMP-1
production in growth factor-treated skin is a complex process. In
part, MMP-1 up-regulation may reflect a direct response of dermal
fibroblasts to the exogenously added EGF. Additionally, however, it
appears that factors elaborated by epidermal keratinocytes play a
role in stimulating dermal fibroblasts to produce MMP-1. This is
based on the finding that culture fluid from keratinocytes grown in
monolayer culture was able to stimulate dermal fibroblasts to
produce MMP-1. Under the culture conditions in which this
occurred, there was no source of exogenous growth factor. In addi-
tion, the time-course for up-regulation of MMP-1 in organ culture
(slower than that for MMP-9) is consistent with an indirect
response to the exogenous stimulus. 
The nature of the keratinocyte-derived factors that influence
fibroblast MMP-1 production remains to be elucidated. The data
suggest that there are at least two factors – one an EGF receptor
agonist and the other an EGF receptor-independent factor. Based
on inhibition data with PD169540, it appears that the EGF receptor
activation plays a relatively minor role in up-regulating fibroblast
MMP-1 production. In contrast, factors acting through the EGF
receptor are more important for stimulating fibroblast growth.
Keratinocytes are known to elaborate a number of molecules that
can activate EGF receptors, including amphiregulin, transforming
growth factor-α and a heparin-binding EGF-like molecule (HB-
EGF) (Elder et al, 1990; Elder, 1994; Stoll et al, 1997). At this
point, we have no way of knowing which of these or other possible
ligands is critical. It should be noted in this regard, however, that
of the known keratinocyte-derived ligands for the EGF receptor,
only HB-EGF is strongly up-regulated in culture (Stoll et al,
1997). 
Since MMP-1 production in organ culture (as well as in fibro-
blasts exposed to keratinocyte culture fluid in monolayer culture)
was only modestly sensitive to EGF-RTK antagonism, ligands
unrelated to the EGF receptor system are likely to be important as
stimulators of this enzyme. IL-1 is one candidate. Both IL-1α and
IL-1β are potent inducers of MMP-1 production in dermal fibrob-
lasts (Mackay et al, 1992; Shingu et al, 1993) and our own unpub-
lished data as well as published reports (Maas-Szabowski et al,
1999, 2000) indicate that the amount of IL-1 elaborated by
keratinocytes in culture (estimated to be up to 450 pg of IL-1α and
100 pg of IL-1β per 1 × 106 cells in a 2-day period) is sufficient to
elicit the fibroblast response. Whether IL-1 is the only non-EGF
receptor ligand involved is not known, but the fact that substantial
inhibition (70–80%) of MMP-1 up-regulation was achieved with
IL-1 Receptor Antagonist suggests that it may be. It is of interest in
this regard that MMP-1 production in keratinocytes may be regu-
lated much differently. It was shown in a recent study by Wan et al
(2001) that keratinocyte production of MMP-1 in response to IL-
1β treatment was sensitive to inhibitors of EGF receptor phospho-
rylation and MAP kinase signalling. The conclusion drawn from
this was that in epidermal keratinocytes, IL-1β induces MMP-1
production via EGF receptor transactivation. 
The phenotype of organ-cultured skin following exposure to
exogenous growth factor treatment (present report and references
Fligiel and Varani, 1993; Varani et al, 1995; Zeigler et al, 1996a,
1996b, 1999) closely mimics the phenotype expressed in actual
epithelial tumours (Weedon, 1997; Brodland, 1998). The proximal
causes of the phenotypic abnormalities may also be similar in
growth factor-treated normal skin and skin tumours. A variety of
defects in EGF signalling pathways have been described in malig-
nant epithelial tumours, including over-expression of ligands
for EGF receptors, over-expression of cell surface EGF receptors
and molecular abnormalities in receptor structure, leading to auto-
activation (Stoscheck and King, 1986; Gottlieb et al, 1988; Ogiso
et al, 1988; Wells, 1999). These defects are thought to underlie
enhanced signalling through MAP kinase pathways with the atten-
dant biological consequences (increased proliferation and MMP
production) that follow. In the same manner, abnormalities in EGF
signalling in malignant epithelial tumours has been shown to result
in enhanced expression of factors such as IL-1 that influenceMMP-1 and invasion 1605
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dermal functions (Mass-Szabowski et al, 1999, 2000). It, thus,
might be concluded that by exposing organ-cultured skin to high
levels of exogenous EGF, we not only induce phenotypic changes
which mimic those expressed by epithelial tumours during inva-
sion, but also duplicate the abnormal signalling events that consti-
tute the proximal cause of the abnormal phenotype. 
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